Epidermal growth factor receptor tyrosine kinase inhibitor - Globe Thesis

Keyword [Epidermal growth factor receptor tyrosine kinase inhibitor] Result: 1 - 20 \| Page: 1 of 4
1.	The Experimental Study On The Effect Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor On Polycystic Kidney Disease
2.	The Pharmacological Study And Phase Ⅰ/Ⅱa Clinical Trial Of Icotinib Hydrochloride In Advanced Non-small Cell Lung Cancer
3.	Study Of 4-AnilinoquinazoIines As Inhibitors Of Tyrosine Kinase Of The Epidermal Growth Factor Receptor
4.	Study Of 4-anilinequinazoline Schiff Bases As Inhibitors Of Tyrosine Kinase Of The Epidermal Growth Factor Receptor
5.	Radiosensitization And Inhibition Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib On Cervical Carcinoma In Vitro
6.	Evaluation Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor To Treat Patients With Advanced Non-small Cell Lung Cancer And Preliminary Study Of DNA Methylation In Lung Cancer Metastasis
7.	Comparing ARMS And Sequencing In Detecting EGFR Mutation And The Prediction Of EGFR-TKI Response In NSCLCs
8.	Observation On The Therapeutic Effect Of Antipruritic Skin Cream On EGFR - TKI - Related Rash
9.	Serum CEA Level Is Associated With Efficacy And Prognosis Of EGFR-TKI Treatment In Non-small Cell Lung Cancer
10.	Quinazolines Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Synthesis Research
11.	Clinical Research Of The Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor In Maintenance Therapy Advanced Non-small Cell Lung Cancer
12.	Efficacy And Prognosis Of The Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor On52Cases Of Advanced Non-small-cell Lung Cancer
13.	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor As Maintenance Therapy For Advanced Non-Small-Cell Lung Cancer: A Meta-analysis Of Randomized Controlled Trials
14.	Individualized Therapy Of Advanced Non-small Cell Lung Cancer With Acquired Resistance To Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
15.	Caveolin-1 Decreases The Sensibility To TKIs In Non-small Cell Lung Cancer Harboring EGFR Mutations
16.	Clinical Observation Of Targeted Drugs As A Therapy On Advanced Non-small Cell Lung Cancer
17.	Erlotinib Enhanced The CIK Cell-mediated Lysis To Lung Adenocarcinoma HCC827 Cells
18.	Efficiency And Safety Of Sequential Treatment Of Icotinib With Chemotherapy In Patients Undergoing Resection Of EGFR Mutation-positive Non-small Cell Lung Cancer
19.	The Relationship With Different Status Of Epidermal Growth Factor Receptor Gene, Clinicopathological Characteristics,prognosis And Therapeutic Effect Of Patients With Non-small Cell Lung Cancer In Qinghai
20.	The Clinical Observation Of Therapeutic Regimens For Slow Progression Advanced NSCLC After First-line EGFR-TKI Therapy
<<First <Prev Next> Last>> Jump to